siRNA, Anti-ATG16L2, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT51294WQ-2OMe)

The product SIRGT51294WQ-2OMe is a type of small interfering RNA (siRNA) that targets ATG16L2 gene and regulates the expression of gene. The siRNA interferes with the expression of ATG16L2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001318766.1
Alternative Names ATG16B; WDR80
Related Diseases Inflammatory Bowel Disease 9
Purification HPLC
Target Gene
Gene ID 89849
Uniprot ID Q8NAA4
Sub Cat Target Species Modification Scale  
SIRGT52294WQ-2F ATG16L2 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT53294WQ-2MOE ATG16L2 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT54294WQ-LNA ATG16L2 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT51294WQ-RB ATG16L2 Human Ribo-modified Inquiry
SIRGT52294WQ-BB ATG16L2 Human Backbone-modified Inquiry

Related Products